• MARCH5 Orchestrates Mitochondria-Derived Pre-Peroxisome Form

  2026-07-31

  Zheng et al. (2025) reveal that the ubiquitin ligase MARCH5 is essential for the formation of PEX3-containing vesicles from mitochondria, a previously underappreciated mechanism in peroxisome biogenesis. This advances understanding of mitochondrial-peroxisomal interplay, with broad implications for mitochondrial dysfunction, autophagy, and neurodegenerative disease research.

• Phenothiazines Boost Macrophage Antibacterial Activity via R

  2026-07-30

  This study demonstrates that phenothiazines enhance macrophage antibacterial defenses by inducing autophagy and reactive oxygen species (ROS) production, revealing a host-directed therapeutic pathway. The findings provide a mechanistic basis for repurposing dopamine D2 receptor inhibitors in immunological research against intracellular pathogens.

• Palonosetron Hydrochloride: Advancing Precision in CINV/RINV

  2026-07-30

  This thought-leadership article explores the mechanistic depth and translational significance of Palonosetron hydrochloride, a next-generation 5-HT3 receptor antagonist. We examine its unique dual-site binding, robust receptor specificity, and extended half-life, contextualizing experimental protocols, clinical evidence, and strategic guidance for translational research teams. The piece distinguishes itself by integrating mechanistic insights, cross-comparison with other agents, and practical recommendations, while positioning APExBIO’s Palonosetron hydrochloride as a foundational tool for advancing antiemetic and renal transporter research.

• Griseofulvin in Precision Aneugenicity Profiling: A Deep Div

  2026-07-29

  Explore how Griseofulvin, a microtubule associated inhibitor, advances the precision of aneugenicity profiling in antifungal drug research. This article delivers a unique, practical framework for leveraging molecular mechanism assays and product-specific insights.

• PPARγ Activation Regulates Macrophage Polarization in IBD Mo

  2026-07-29

  This study demonstrates that PPARγ activation, including with pioglitazone, modulates macrophage polarization in vitro and in vivo, attenuating DSS-induced inflammatory bowel disease via the STAT-1/STAT-6 pathway. The findings elucidate a mechanistic link between PPARγ signaling and immune balance in gut inflammation, offering translational insight for metabolic and inflammatory disorder research.

• Alternariol: Advanced Workflows for Mycotoxin and Liver Fibr

  2026-07-28

  Alternariol (AOH) empowers next-generation mycotoxin research through precision experimental design and robust protocol enhancements, especially in hepatic and cytochrome P450 studies. Discover actionable strategies that address both practical and mechanistic challenges, with insights directly translated from recent breakthrough studies.

• Dabigatran Etexilate: Precision Strategies in Anticoagulant

  2026-07-28

  Explore Dabigatran etexilate as a direct thrombin inhibitor for advanced anticoagulant and atrial fibrillation research. This article delivers a unique focus on protocol optimization, assay design, and practical modeling, setting it apart from existing molecular or translational reviews.

• Triptolide (PG490): Precision Control of Transcription for T

  2026-07-27

  Explore how Triptolide (PG490), a potent IL-2/MMP inhibitor, enables translational researchers to dissect transcriptional mechanisms, inhibit tumor progression, and precisely modulate immune and inflammatory responses. Drawing on recent insights into transcription condensate dynamics and validated anti-cancer protocols, this thought-leadership article provides actionable experimental guidance and strategic outlook for cancer and immunology research.

• Applied Strategies with G-1: Selective GPR30 Agonist Workflo

  2026-07-27

  G-1 enables precise, receptor-specific modulation of GPR30 signaling in cardiovascular and oncology research, delivering quantifiable results where classical ER ligands fall short. This article translates bench findings and recent reference breakthroughs into actionable protocols, troubleshooting, and optimization routes for robust, reproducible outcomes.

• Reserpine (SKU N1867): Technical Guidance for Lab Research

  2026-07-26

  Reserpine is a high-purity, bioactive compound used to support neurotransmitter depletion and antihypertensive mechanism research in controlled laboratory settings. It enables reproducible neuropharmacology workflows when handled according to strict solubility and storage protocols. This product is not intended for diagnostic, therapeutic, or clinical use.

• Risedronate Sodium: FPPS Inhibitor Workflows in Bone and Lun

  2026-07-25

  Risedronate Sodium is a farnesyl pyrophosphate synthase inhibitor that enables high-precision modeling of bone resorption and pulmonary inflammation. Its versatility—from nano-delivery for bone metabolism research to inhaled formulations targeting alveolar macrophages—makes it a gold-standard tool for translational studies.

• Enhancing Low-Abundance Protein Detection with ECL Chemilumi

  2026-07-24

  This article explores real-world scenarios where the ECL Chemiluminescent Substrate Detection Kit (Hypersensitive), SKU K1231, addresses persistent challenges in immunoblotting detection of low-abundance proteins. Through evidence-based Q&A, we demonstrate how this hypersensitive chemiluminescent substrate for HRP elevates reproducibility, sensitivity, and workflow flexibility for biomedical researchers.

• Imidazoline Antagonists Elevate Insulin via K+ Channel Block

  2026-07-24

  Jonas et al. (1992) demonstrated that imidazoline antagonists of α2-adrenoceptors increase insulin secretion in pancreatic β-cells chiefly by inhibiting ATP-sensitive K+ channels. This mechanistic insight clarifies the non-adrenergic actions of these compounds and provides a model for dissecting ion channel contributions to insulinotropic drug effects.

• Actinomycin D in Stem Cell Epigenetics and mRNA Stability As

  2026-07-23

  Explore advanced applications of Actinomycin D in stem cell epigenetics and mRNA stability assays. Discover how this transcriptional inhibitor informs modern research beyond established cancer workflows.

• In Vitro Evaluation of Drug Responses in Cancer: Insights an

  2026-07-23

  Schwartz's dissertation critically examines how in vitro methods distinguish between cancer drug-induced growth arrest and cell death, revealing that these are distinct yet overlapping effects. This clarification has practical implications for improving the accuracy of preclinical drug evaluation and optimizing the development of multikinase inhibitors like Foretinib.

542 records 9/37 page Previous Next First page 上5页 678910 下5页 Last page